Comparison of Risperidone and Mosapramine Addition to Neuroleptic Treatment in Chronic Schizophrenia

Publisher： Karger

E-ISSN： 1423-0224|39|2|81-85

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.39, Iss.2, 1999-03, pp. : 81-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risperidone Treatment of Schizophrenia: Improvement in Psychopathology and Neuropsychological Tests

By  

Neuropsychobiology, Vol. 46, Iss. 2, 2002-10 ,pp. : 85-89

Karger

Access to resources Recommend Favorite

Hippocampal Volume in Schizophrenia and Its Relationship with Risperidone Treatment: A Stereological Study

By  

Neuropsychobiology, Vol. 46, Iss. 2, 2002-10 ,pp. : 61-66

Karger

Access to resources Recommend Favorite

Increased Plasma Brain-Derived Neurotropic Factor, Not Nerve Growth Factor-Beta, in Schizophrenia Patients with Better Response to Risperidone Treatment

By  

Neuropsychobiology, Vol. 59, Iss. 1, 2009-03 ,pp. : 51-58

Karger

Access to resources Recommend Favorite

Comparison of Risperidone Orodispersible Tablet and Intramuscular Haloperidol in the Treatment of Acute Psychotic Agitation: A Randomized Open, Prospective Study

By  

Neuropsychobiology, Vol. 62, Iss. 2, 2010-06 ,pp. : 81-86

Karger

Access to resources Recommend Favorite

Lower Corneal Temperature in Neuroleptic-Treated vs. Drug-Free Schizophrenia Patients

By  

Neuropsychobiology, Vol. 48, Iss. 1, 2003-07 ,pp. : 1-4

Karger

Access to resources Recommend Favorite